Although mechanisms by which lack of HO-2 causes metabolic derangement in the contralateral hemisphere remain unknown, these results shed light on a potential paradigm shift of treatment of stroke from conventional management of local vascular re-canalization towards global management including control of transhemispheric diaschisis as a whole brain. This evidence concerns the gene HMOX2 and Stroke.